Related Experiment Video
Updated: Jul 3, 2026

An Ex Vivo Chicken Primary Bursal-cell Culture Model to Study Infectious Bursal Disease Virus Pathogenesis
Published on: October 4, 2018
A recombinant subunit vaccine that protects progeny chickens from infectious bursal disease
K J Fahey1, A J Chapman, I G Macreadie
1CSIRO Division of Animal Health, Animal Health Research Laboratory, Parkville, Victoria, Australia.
Abstract:
The major protective immunogen of infectious bursal disease virus (IBDV), VP2, was produced in a highly immunogenic form by expression in the yeast Saccharomyces cerevisiae. The recombinant protein, formulated as an oil-emulsion vaccine, induced both virus neutralising and ELISA antibodies in specific pathogen free hens. These antibodies were passed, via the egg yolk, to progeny chickens and protected them against a challenge infection with virulent IBDV. The protective efficacy of maternal antibodies to the recombinant VP2, as assessed by ELISA, was comparable to that of antibodies to the whole virus. The recombinant subunit vaccine induced anamnestic serum antibody responses in hens primed previously with live virus, and hence can replace the conventional inactivated vaccines administered to breeding hens.
Related Concept Videos
Chickenpox
Vaccinations
Vaccine Production
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Respiratory Syncytial Virus Disease
Vaccines

